Header Logo

Connection

WOLFGANG WINKELMAYER to Symporters

Back to Details
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Symporters.
WOLFGANG WINKELMAYER
Connection Strength
0.190
Symporters
  1. Cardiovascular outcomes associated with prescription of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with diabetes and chronic kidney disease. Diabetes Obes Metab. 2022 05; 24(5):928-937.
    View in: PubMed
    Score: 0.190
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.